The new Stryker Hip Replacement Helpline is assisting people with the recalled Stryker hip replacements.
This includes the Rejuvenate Modular Primary Hip System and Rejuvenate Total Hip System which have been recalled due to possible side effects similar to those seen in metal-on-metal hip implants.
On July 4, 2012, Stryker issued a voluntary product recall of its Rejuvenate Modular and ABG II modular-neck hip stems. According to Stryker, the recall was initiated due to the potential risks associated with modular-neck stems, including fretting and/or corrosion at or around the modular-neck junction. This can lead to pain and/or swelling at the joint.
The Stryker Hip Replacement Helpline has been launched for victims of the Stryker voluntary recall of the Stryker ABG II modular-neck stem used for total hip replacement surgery and the Stryker Rejuvinate modular-neck stem hip implant.
Complications and Injuries include:
- Severe inflammatory reactions
- Pain in the groin
- Need for additional medical care and revision surgeries
- Breakdown of muscles, tendons and other soft tissues in and around the hip joint
- Loss of surrounding bone
- Loss of mobility
The Stryker Rejuvenate side effects appear to be similiar to the Metal on Metal Hip Replacements that have caused a landslide of lawsuits against DePuy Orthopedics.
While other types of hip implants such as those made by Johnson & Johnson and DePuy Orthopaedics Inc. involve a metal ball rubbing against a metal socket, the Stryker Rejuvenate products involve a metal neck inside a metal stem. It appears That lawyers are beginning to build cases against Stryker as a part of the complete metal on metal hip replacement lawsuits. Stryker does run the risk of metal toxicity as chromium and cobalt paoisoning may occur.
Anyone experiencing side effects from these Stryker products is advised to call the Stryker Hip Replacement Helpline for a Stryker Hip Replacement lawyer.
Stryker states that the rate of complications arising from the recalled devices was "extremely low." The company based its recall decision on information collected since the products hit the market, saying it "may be predictive of a trend." It instructed patients implanted with the devices to contact their surgeon.